UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
April 10, 2006
VisualMED Clinical Solutions Corp.
(Exact name of registrant as specified in its charter)
NEVADA |
000-33191 |
88-0436055 |
(State or other jurisdiction of incorporation) |
(Commission File No.) |
(IRS Employer ID) |
1035 Laurier Street West
Montreal, Quebec H2V 2L1
(Address of principal executive offices and Zip Code)
(514) 274-1115
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
£ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
£ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
£ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
£ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 |
Regulation FD Disclosure |
VisualMED Clinical Solutions Corp. (OTC BB: VMCS) enters into an agreement with Canadian consortium to implement first ever private network linking medical clinics to other healthcare services.
The deal is expected to be worth close to $3.4 M to the Company over the next two years in its first phase, and could be worth another $2 M in the subsequent phase.
Item 9.01 |
Financial Statements and Exhibits | |
Exhibit 99.1 |
Press Release dated April 10, 2006 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated this 10th day of April, 2006.
VisualMED Clinical Solutions Corp.
By: |
/s/ Gerard Dab |
|
|
Gerard Dab, Chief Executive Officer |